ABBVIE INC. (ABBV)
Clinical trial NCT07291232 updates: 1. completion date: 2026-10-01 → 2027-03-01 2. primary completion date: 2026-10-01 → 2027-03-01 3. enrollment: 48 → 80 participants
Clinical trial NCT07291232 updates: 1. completion date: 2026-10-01 → 2027-03-01 2. primary completion date: 2026-10-01 → 2027-03-01 3. enrollment: 48 → 80 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical